{
    "eid": "2-s2.0-85041902085",
    "title": "Targeted orexin and hypothalamic neuropeptides for migraine",
    "cover-date": "2018-02-13",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Hypothalamus",
        "Migraine",
        "Neuropeptide Y (NPY)",
        "Orexin",
        "Oxytocin",
        "Pituitary adenylate cyclase activating protein (PACAP)"
    ],
    "authors": [
        "Lauren C. Strother",
        "Anan Srikiatkhachorn",
        "Weera Supronsinchai"
    ],
    "citedby-count": 33,
    "ref-count": 172,
    "ref-list": [
        "The hypothalamus",
        "New therapeutic approaches for the prevention and treatment of migraine",
        "Pathophysiology of Migraine: A Disorder of Sensory Processing",
        "Polysomnographic findings in nights preceding a migraine attack",
        "Premonitory symptoms in migraine: An electronic diary study",
        "Brain activations in the premonitory phase of nitroglycerin-trig-gered migraine attacks",
        "The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks",
        "Dopamine hypersensitivity in migraine: Role of the apomorphine test",
        "Cranial autonomic symptoms in migraine: Characteristics and comparison with cluster headache",
        "A direct hypothalamic projection to the superior salivatory nucleus neurons in the rat. A study using anterograde autoradiographic and retrograde HRP methods",
        "Descending projections from the hypothalamic paraventricular nucleus to the A5 area, including the superior salivatory nucleus, in the rat",
        "The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-fos immunocytochemical study",
        "Dural headache and innervation of the dura mater",
        "Cells of origin of the trigeminohypothalamic tract in the rat",
        "Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches",
        "Changes of meningeal excitability mediated by corticotrigeminal networks: A link for the endogenous modulation of migraine pain",
        "Diencephalic and brainstem mechanisms in migraine",
        "Hypothalamus and Nociceptive Pathways",
        "Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating",
        "Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by medial preoptic and septal stimulation in the cat",
        "Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)-and alpha(2)-adrenoceptors",
        "Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist",
        "Hypothalamic activation in spontaneous migraine attacks",
        "Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area",
        "Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus",
        "Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: A Fos study",
        "Trigeminal nociceptive transmission in migraineurs predicts migraine attacks",
        "Organization and function of a central nervous system circadian oscillator: The suprachiasmatic hypothalamic nucleus",
        "Migraine chronobiology",
        "24-Hour Distribution of Migraine Attacks",
        "Circadian rhythms of plasma cortisol in migraine",
        "Prospective analysis of factors related to migraine attacks: The PAMINA study. Cephalalgia: An international journal of",
        "Trigger factors of migraine and tension-type headache: Experience and knowledge of the patients",
        "Headache and sleep: Examination of sleep patterns and complaints in a large clinical sample of migraineurs",
        "Migraine treatment: The British perspective",
        "Resolution of migraine attacks: Sleep and the recovery phase",
        "Insomnia and Circadian Variation of Attacks in Episodic Migraine",
        "Increased frequency of migraine in narcoleptic patients: A confirmatory study",
        "Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome",
        "Melatonin-responsive headache in delayed sleep phase syndrome: Preliminary observations",
        "Method of precipitating and preventing some migraine attacks",
        "The triggers or precipitants of the acute migraine attack",
        "Modifiable risk factors for migraine progression",
        "GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs",
        "Insulin metabolism is altered in migraineurs: A new pathogenic mechanism for migraine?",
        "Insulin sensitivity is impaired in patients with migraine",
        "A neurohistochemical blueprint for pain-induced loss of appetite",
        "The hypocretins/orexins: Novel hypothalamic neuropeptides involved in different physiological systems",
        "Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior",
        "Neurons containing hypocretin (Orexin) project to multiple neuronal systems",
        "Differential expression of orexin receptors 1 and 2 in the rat brain",
        "The orexin/hypocretin system: A critical regulator of neuroendocrine and autonomic function",
        "The hypocretins/orexins: Integrators of multiple physiological functions",
        "Fos expression in orexin neurons varies with behavioral state",
        "Release of hypocretin (Orexin) during waking and sleep states",
        "Orexin-induced food intake involves neuropeptide Y pathway",
        "Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat",
        "Orexins (Hypocretins) directly interact with neuropeptide Y, POMC and glucose-respon-sive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: Orexigenic neuronal pathways in the mediobasal hypothalamus",
        "Effects of changes in energy homeostasis and exposure of noxious insults on the expression of orexin (Hypocretin) and its receptors in the brain",
        "Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex",
        "Hypothalamic orexin expression: Modulation by blood glucose and feeding",
        "Orexin A activates locus coeruleus cell firing and increases arousal in the rat",
        "Hypocretins (Orexins) Regulate Serotonin Neurons in the Dorsal Raphe Nucleus by Excitatory Direct and Inhibitory Indirect Actions",
        "Orexins activate histaminergic neurons via the orexin 2 receptor",
        "Hypocretin (Orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system",
        "Reduced number of hypocretin neurons in human narcolepsy",
        "Involvement of cortico-trophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: Findings from cerebrospinal fluid",
        "The hypothalamic orexinergic system: Pain and primary headaches",
        "Distribution of orexin neurons in the adult rat brain",
        "Antinociceptive effects of orexin A in the vlPAG are blocked by 5HT1B/1D receptor antagonism",
        "Afferents to the orexin neurons of the rat brain",
        "Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia",
        "Pharmacological characterization of MK-6096-a dual orexin receptor antagonist for insomnia",
        "Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization",
        "Evidence for orexinergic mechanisms in migraine",
        "Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception",
        "Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat",
        "The Role of the orexin-2 receptor in the nucleus raphe magnus on trigeminovascular nociceptive transmission",
        "Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis",
        "Putting migraine to sleep: Rexants as a preventive strategy",
        "The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin",
        "Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat",
        "60 years of neuroendocrinology: The posterior pituitary, from Geoffrey Harris to our present understanding",
        "Investigation of the oxytocin receptor at the molecular level",
        "Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders",
        "Migraine in pregnancy",
        "Oxytocin levels in maternal and fetal plasma, amniotic fluid, and neonatal plasma and urine",
        "Postpartum migraines: A long-term prospective study. Internal medicine (Tokyo",
        "An investigation of plasma and salivary oxytocin responses in breast-and formula-feeding mothers of infants",
        "Plasma oxytocin increases in the human sexual response",
        "Orgasm and migraine",
        "Relief of acute migraine headache with intravenous oxytocin: Report of two cases",
        "Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment",
        "CGRP receptor antagonism and migraine",
        "CGRP and its receptors provide new insights into migraine pathophysiology",
        "Central oxytocin enhances antinociception in the rat",
        "Oxytocin in the periaqueductal grey regulates nociception in the rat",
        "Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia",
        "Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V1A receptors",
        "Brain uptake and the analgesic effect of oxy-tocin\u2013its usefulness as an analgesic agent",
        "Oxytocin and Migraine Headache",
        "Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells",
        "Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes",
        "Biological and structural analysis of truncated analogs of PACAP27",
        "Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs",
        "Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery",
        "PACAP is implicated in the stress axes",
        "Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo",
        "Pituitary adenylate cyclase activating polypeptide immunoreactivity in the rat spinal cord and medulla: Implication of sensory and autonomic functions",
        "Fine structural correlates of VIP-like immunoreactivity in the upper spinal dorsal horn after peripheral axotomy: Possibilities of a neuro-glial trans-location of a neuropeptide",
        "Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence",
        "Pituitary adenylate cyclase activating polypeptide expression in sensory neurons",
        "Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord",
        "Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions",
        "PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells",
        "PACAP receptor pharmacology and agonist bias: Analysis in primary neurons and glia from the trigeminal ganglia and transfected cells",
        "Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems",
        "Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia",
        "Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood\u2013brain barrier",
        "Pituitary adenylate cyclase activating polypeptide and migraine",
        "Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients",
        "Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache",
        "No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine",
        "PACAP38 induces migraine-like attacks in patients with migraine without aura",
        "Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38",
        "PACAP38 dose-response pilot study in migraine patients",
        "Change in brain network connectivity during PACAP38-induced migraine attacks: A rest-ing-state functional MRI study",
        "Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine",
        "Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients",
        "Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine",
        "The PACAP receptor: A novel target for migraine treatment",
        "PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor",
        "Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine",
        "Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: Implications for migraine",
        "Neuropeptide Y: Complete amino acid sequence of the brain peptide",
        "Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas",
        "Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain",
        "NPY and Y receptors: Lessons from transgenic and knockout models",
        "Central nervous system control of food intake and body weight",
        "Neuropeptide Y: A stressful review",
        "The role of Neuropeptide Y in fear conditioning and extinction",
        "NPY receptors as potential targets for anti-obesity drug development",
        "VIP and NPYexpres-sion during differentiation of cholinergic and noradrenergic sympathetic neurons",
        "Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus",
        "NPY and cardiac diseases",
        "Importance of NPY Y1 receptor-mediated pathways: Assessment using NPY Y1 receptor knockouts",
        "XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors",
        "Effect of peripheral axotomy on expression of neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia",
        "Neuropeptide Y Y1 receptor antagonist (BIBP 3226) attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats",
        "Current views on neuropeptide Y and diabetes-related atherosclerosis",
        "Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensi-tive G protein",
        "Photo-, osmo-and phonophobia in the premonitory phase of migraine: Mistaking symptoms for triggers?",
        "Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries",
        "First study on the peptidergic innervation of the brain superior sagittal sinus in humans",
        "Neuropeptide Y in juvenile migraine and tension-type headache",
        "Vasoactive peptide release in the extracerebral circulation of humans during migraine headache",
        "Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine",
        "Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF",
        "Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: The results of a pilot study",
        "Endogenous analgesia, dependence, and latent pain sensitization",
        "Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism",
        "Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors",
        "Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors",
        "Intrathecal neuropeptide Y inhibits behavioral and cardiovascular responses to noxious inflammatory stimuli in awake rats",
        "Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain",
        "Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY",
        "Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation",
        "Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: Implications for migraine",
        "Human pineal physiology and functional significance of melatonin",
        "Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses",
        "Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention",
        "Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ladkrabang Bangkok",
            "@id": "60021543",
            "affilname": "King Mongkut's Institute of Technology Ladkrabang",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60011520",
            "affilname": "King's College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011520",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}